Human papillomavirus vaccine effectiveness by age at vaccination: a systematic review
MK Ellingson, H Sheikha, K Nyhan… - Human Vaccines & …, 2023 - Taylor & Francis
Human papillomavirus (HPV) vaccines work by preventing infections prior to natural
exposure. Thus, it is likely more effective at younger ages, and it is important to understand …
exposure. Thus, it is likely more effective at younger ages, and it is important to understand …
Impact of human papillomavirus vaccination on male disease: a systematic review
C Rosado, ÂR Fernandes, AG Rodrigues, C Lisboa - Vaccines, 2023 - mdpi.com
Human papillomavirus (HPV)-related diseases are highly prevalent in men worldwide,
comprising external anogenital condyloma, anal intraepithelial neoplasia (AIN), penile …
comprising external anogenital condyloma, anal intraepithelial neoplasia (AIN), penile …
Vaccines for HPV-associated diseases
JM Skolnik, MP Morrow - Molecular Aspects of Medicine, 2023 - Elsevier
Human papillomavirus (HPV) infection represents a significant global health concern owing
to its role in the etiology of conditions ranging from benign low-grade lesions to cancers of …
to its role in the etiology of conditions ranging from benign low-grade lesions to cancers of …
Opportunities and challenges for human papillomavirus vaccination in China
C Zhao, Y Zhao, J Li, M Li, Y Shi… - Human Vaccines & …, 2024 - Taylor & Francis
Current estimates of the HPV infection rate in China vary by geographic region (9.6–23.6%),
with two age peaks in prevalence in women≤ 20–25 years of age and 50–60 years of age …
with two age peaks in prevalence in women≤ 20–25 years of age and 50–60 years of age …
HPV Vaccination for Cervical Cancer Prevention in Switzerland
Definition Human papillomavirus (HPV) is responsible for almost all cases of cervical cancer
worldwide. It is also responsible for a variety of other cancers including penile; vaginal; …
worldwide. It is also responsible for a variety of other cancers including penile; vaginal; …
[HTML][HTML] Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the Onclarity trial
MH Stoler, TC Wright Jr, V Parvu, K Yanson… - Gynecologic …, 2023 - Elsevier
Abstract Objectives The Onclarity cervical cancer screening trial was designed to establish
the clinical validity of the Onclarity HPV assay for extended genotyping (xGT) during …
the clinical validity of the Onclarity HPV assay for extended genotyping (xGT) during …
Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination
Cervical cancer is the first cancer deemed amenable to elimination through prevention, and
thus lessons from the epidemiology and prevention of this cancer type can provide …
thus lessons from the epidemiology and prevention of this cancer type can provide …
The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)
F Movahed, S Darzi, P Mahdavi, M Salih Mahdi… - Virology Journal, 2024 - Springer
Cervical cancer (CC) and other malignant malignancies are acknowledged to be primarily
caused by persistent human papillomavirus (HPV) infection. Historically, vaccinations …
caused by persistent human papillomavirus (HPV) infection. Historically, vaccinations …
Mapping the Research Landscape of HPV-Positive Oropharyngeal Cancer: a Bibliometric Analysis
Objective The aim of the study is to evaluate the scientific interest, the collaboration patterns
and the emerging trends regarding HPV+ OPSCC diagnosis and treatment. Materials and …
and the emerging trends regarding HPV+ OPSCC diagnosis and treatment. Materials and …
Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts
Human papillomavirus (HPV) is a common sexually transmitted virus that can cause cervical
cancer and other diseases. Dynamic transmission models (DTMs) have been developed to …
cancer and other diseases. Dynamic transmission models (DTMs) have been developed to …